To investigate the anti-psoriatic mechanisms of Solanum nigrum (SN) and identify its major bioactive component, emphasizing the significance of these mechanisms in psoriasis treatment.
Key Findings:
NLRP3 inflammasome activation was elevated in psoriatic lesions, indicating its role in disease pathology.
SN significantly reduced disease severity and keratinocyte hyperproliferation, highlighting its therapeutic potential.
SN lowered systemic inflammatory cytokine levels, suggesting a broad anti-inflammatory effect.
Transcriptomic analysis indicated SN modulated PRR/NLR-related signaling pathways, providing a mechanistic understanding.
Trigonelline was identified as a major active constituent contributing to SN's anti-psoriatic effects, underscoring its importance in treatment.
Interpretation:
SN ameliorates psoriasis-like dermatitis primarily by suppressing NLRP3 inflammasome signaling, with trigonelline as a key active component, suggesting avenues for future research and clinical application.
Limitations:
The study primarily focused on animal models, which may not fully replicate human psoriasis, potentially limiting the applicability of findings.
Further clinical studies are needed to validate the findings in human subjects to ensure relevance to patient care.
Conclusion:
These findings provide mechanistic support for the therapeutic application of SN in psoriasis treatment, emphasizing its potential role in clinical practice.
